Animal cells and systems

The Korean Society for Integrative Biology (한국통합생물학회)
권호 표지

Genetic Variations in Six Candidate Genes for Insulin Resistance in Korean Essential Hypertensives

  • Bae, Joon-Seol (Seoulin Bioscience Institute, Seoulin Bioscience, Co, Ltd.) ;
  • Kang, Byung-Yong (Seoulin Bioscience Institute, Seoulin Bioscience, Co, Ltd.) ;
  • Kim, Ki-Tae (Seoulin Bioscience Institute, Seoulin Bioscience, Co, Ltd.) ;
  • Shin, Jung-Hee (School of Biological Sciences, Seoul National University) ;
  • Lee, Chung-Choo (School of Biological Sciences, Seoul National University)
  • Published : 2001.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Hypertension is a complex disease with strong genetic influences. Essential hypertension has been shown to be associated with insulin resistance. To clarify the genetic basis of insulin resistance in Hypertension, case-control association studies were performed to examine candidate genes for insulin resistance in hypertension. Polymorphisms investigated were the BstO I polymorphism of the $\beta$3-adrenergic receptor (ADRB3) gene, the Xba I Polymorphism of the glycogen synthase (GSY) gene, the Dde I polymorphism of the protein phosphatase 1 G subuit (PP1G) gene, the BstE II polymorphism of the glucagon receptor (GCG-R) gene, the Pst 1 polymorphism of the insulin (INS) gene and the Acc I polymorphism of the glucokinase (GCK) gene. No significant differences were observed in the distribution of alleles and genotypes of the ADRB3, GSY PP1G, GCG-R, INS, and GCK genes between hypertensive and normotensive groups. Although the frequencies in each of these polymorphisms were not significantly different between essential hypertensive and normotensive individuals, our results may provide additional information for linkage analysis and associative studies of disorders in carbohydrate metabolism or in cardiovascular disease.

Keywords

References

  1. Biery AJ, Ebbesson SOE, Shuldiner AR, and Boyer BB (1997) The ${\beta}_3$ -adrenergic receptor TRP64ARG polymorphism and obesity in Alaskan Eskimos. Int J Obes Relat Metab Disord 21: 1176-1179 https://doi.org/10.1038/sj.ijo.0800532
  2. Cemilla S-J, Pirjo N-I, Xudong H, Markku L, Petteri K, Mikko S, Mikko TL, Tuula T, Ilkka T, and Leif CG (1996) Polymorphism of the glycogen synthase gene in hypertensive and normotensive subjects. Hypertension 27: 67-71
  3. Cherrington AD and Liljenquist JE (1981) Role of glucagon in regulating glucose production in vivo. In: Unger RH and Orci L (eds), Glucagon. Elsevier North-Holland, New York. pp 221-253
  4. Chiang F-T, Chiu KC, Tseng Y-Z, Lee K-C, and Chuang L-M (1997) Nucleotide(-258) G-to-A transition variation of the liver glucokinase gene is associated with essential hypertension. Am J Hypertens 10: 1049-1052 https://doi.org/10.1016/S0895-7061(97)00281-1
  5. Chiu KC, Go RCP, Aoki M, Riggs AC, Tanizawa Y, Acton RT, Bell DSH, Goldenberg RL, Roseman JM, and Permutt MA (1994) Glucokinase gene in gestational diabetes mellitus:population association study and molecular scanning. Diabetologia 37: 104-110 https://doi.org/10.1007/BF00428785
  6. Clement K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, and Strosberg AD (1995) Genetic variation in the beta(3)-adrenergic-receptor and an inceased capacity to gain weight in patients with morbid obesity. N Engl J Med 333: 352-354 https://doi.org/10.1056/NEJM199508103330605
  7. DeFronzo RA and Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194 https://doi.org/10.2337/diacare.14.3.173
  8. Elbein SC, Hoffman M, Qin H, Chiu K, Tanizawa Y, and Pemutt MA (1994) Molecular screening of the glucokinase gene in familial type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 37: 182-187 https://doi.org/10.1007/s001250050091
  9. Fenger M, Poulsent P, Beck-Nielsent H, and Vaag A (2000) Impact of the Xba I-Polymorphism of the human muscle glycogen synthase gene on parameters of the insulin glycogen synthase gene on parameters of the insulin resistance syndrome in a Danish twin population. Diabetic Med 17: 735-740 https://doi.org/10.1046/j.1464-5491.2000.00377.x
  10. Ferrannini E, Buzzigoli G, and Bonadonna R (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350-357
  11. Friedwald WT, Levy RI, and Fridrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502
  12. Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris L, Shuman WP, Stolov WC, Wahl PW (1987) Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36: 721-729 https://doi.org/10.2337/diabetes.36.6.721
  13. Graeme IB, Raymond LP, William JR, Barbara C, Edmund T, and Howard MG (1980) Sequence of the human insulin gene. Nature 284: 26-32 https://doi.org/10.1038/284026a0
  14. Gulja B, Bruno A, Felix B, Alexander C, and Martin R (1997) Polymorphism of the glycogen synthase gene and non-insulin dependent diabetes mellitus in the Russian population. Metabolism 46: 121-123 https://doi.org/10.1016/S0026-0495(97)90287-0
  15. Hansen L, Hansen T, Vestergaar H, Bjbaek C, Echwald SM, Clausen JO, Chen YH, Chen MX, Cohen PTW, and Pederson O (1995) A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphtase-1 is associated with insulin resistance and hypersecretion of insulin. Hum Mol Gent 4: 1313-1320 https://doi.org/10.1093/hmg/4.8.1313
  16. Harger J, Hansen L, Vaisse C, Vionnet N, Philippi A, Poller W, Velho G, Carcassi C, Contu L, Julier C, Cambien F, Passa P, Lathrop M, Kindsvogel W, Demenais F, Nishimura E, and Froguel P (1995) A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet 9: 299-304 https://doi.org/10.1038/ng0395-299
  17. Hubbard MJ, and Cohen P (1993) On target with a new mechanism for the regulation of protein phosphorylation. Tresnds Biochem Sci 18: 172-177 https://doi.org/10.1016/0968-0004(93)90109-Z
  18. Ikegami H, Yamaoto E, Fujisawa T, Hamada Y, Fujioka Y, Rakugi H, Higaki J, Murakami H, Shimamoto K, and Ogihara T (1996) Analysis of candidate genes for insulin resistance in essential hypertension. Hypertens Res 19: S31-S34
  19. Kadowaki H, Yasuda K, and Iwamoto K (1995) A mutation in the beta(3)-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japan subjects. Biochem Biophys Res Commun 215: 555-560 https://doi.org/10.1006/bbrc.1995.2500
  20. Kang BY, Kim KT, Eo HS, Lee KH, Hong SS, Shin JH, and Lee CC (2000) Association between genetic variation of the insulin receptor gene and essential hypertension in the Korean population. Korean J Biol Sci 4: 87-90
  21. Kawai K, Yokota C, Watanabe Y, and Yamashita K (1995) Evidence that glucagon stimulates insulin secretion through its own receptor in rats. Diabetologia 38: 274-276 https://doi.org/10.1007/BF00400630
  22. Kida Y, Esposito-Del P, Bogardus C, and Mott DM (1990) Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. J Clin Invest 85: 76-481
  23. Kida Y, Raz I, Maeda R, Nyomba BL, Stone K, Bogardus C, Sommercorn J, and Mott DM (1992) Defective insulin response of phosphorylase physphatase in insulin-resistant humans. J Clin Invest 89: 610-617
  24. Kristi S, Braxton DM, Jeremy W, John DS, Michael PS, Jesse R, and Alan RS (1997) TRP64ARG ${\beta}_3$ -adrenergic receptor and obesity in Mexican Americans. Hum Genet 101: 306-311 https://doi.org/10.1007/s004390050633
  25. Kurabayashi T, Carey DGP, and Morrison NA (1996) The ${\beta}_3$ -adrenergic receptor Trp64Arg mutation is overrepresented in obese women. Diabetes 45: 1358-1362 https://doi.org/10.2337/diabetes.45.10.1358
  26. Kuroyama H, Sanke T, Ohagi S, Furuta M, Furuta H, and Nanjo K (1994) Simple tandom repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetes 37: 536-539 https://doi.org/10.1007/s001250050144
  27. Lander ES, and Schork NJ (1994) Genetic dissection of complex traits. Science 265: 2037-2048 https://doi.org/10.1126/science.8091226
  28. Leann O, Rachel J, Cris W, and Alan PM (1992) Variability of the insulin gene in American blacks with NIDDM. Diabetes 41: 742-749 https://doi.org/10.2337/diabetes.41.6.742b
  29. Maglasson MD, and Matschinsky FM (1984) New perspective on pancreatic islet glucokinase. Am J Physiol 246: E1-13
  30. Maglasson MD and Matschinsky FM (1986) Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev 2: 163-214
  31. Magnuson MA (1990) Glucokinase gene structure: functional implications of molecular genetic studies. Diabetes 39: 523-527 https://doi.org/10.2337/diabetes.39.5.523
  32. Matschinsky FM (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic α-cells and hepatocytes. Diabetes 39: 647-652 https://doi.org/10.2337/diabetes.39.6.647
  33. Paul RH and Anna MK (1991) Pstl polymorphism within the 3' untranslated region of the insulin gene detectable by the polymerase chain reaction (INS). Nucleic Acids Res 19: 4576 https://doi.org/10.1093/nar/19.16.4576-a
  34. Ravean GM, Lithell H, and Landsberg L (1996) Hypertension and associated metabolic abnormalities-the role of insulin resistance and sympathoadrenal system. N Engl J Med 334: 374-381 https://doi.org/10.1056/NEJM199602083340607
  35. Revelli JP, Muzzin P, and Paoloni A (1993) Expression of the ${\beta}_3$ -adrenergic receptor in white adipose tissue. J Mol Endocrinol 10: 193-197
  36. Sambrook J, Fritsch EF, and Maniatis T (1989) Molecular Cloning: a Laboratory Manual. 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 9.16-9.23
  37. Shen DC, Shieh SM, and Fuh MM (1988) Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66: 580-583
  38. Shen G-Q, Ikegami H, Fujisawa T, Hamada Y, Kamide K, Rakugi H, Higaki J, Murakami H, Shimamoto K, and Ogihara T (1997) Asp905Tyr polymorphism of protein phosphatase 1G subunit gene in hypertension. Hypertension 30: 236-239
  39. Stephan M, Markus S, Rafael E, Anthony AF, Michelle MLB, and Graeme IB (1993) Localization of the glucagon receptor gene to human chromosome band 17q25. Genomics 20: 327-328 https://doi.org/10.1006/geno.1994.1179
  40. Stone LM, Kahn SE, Deeb SS, Fujimoto WY and Porte D Jr (1994) Glucokinase gene variations in Japanese-Americans with a family history of NIDDM. Diabetes Care 17: 1480-1483 https://doi.org/10.2337/diacare.17.12.1480
  41. Strfors P, Hiraga A, and Cohen P (1985) The protein Phosphatase involved in cellular regulation: purification and characterisation of the glycogen-bound form of protein phosphatase-q from rabbit skeletal muscle. Eur J Biochem 149: 295-303 https://doi.org/10.1111/j.1432-1033.1985.tb08926.x
  42. Tai TY, Chuang LM, Chen Cj, and Lin BJ (1991) Link between hypertension and diabetes mellitus. Epidemiological study of chinese adults in Taiwan. Diabetes Care 14: 1013-1320 https://doi.org/10.2337/diacare.14.11.1013
  43. Tang PM, Bondor EJA, Swiderek KM, and DePaoli-Roach AA (1991) molecular cloning and expressin of the regulatory R(G1) subunit of the glyscogen-associated protein phosphatase. J Biol Chem 266: 15782-15789
  44. Unger RH and Orci L (1990) Glucagon. In: Rifkin H and Porte D(eds), Ellenberg and Rifkin's Diabetes Mellitus Theory and Practice. Elsevier, New York. pp 104-120 https://doi.org/10.2337/diabetes.45.8.1115
  45. Urhammeret SO, Clausen JO, Hansen T, and Pedersen O (1996) Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the ${\beta}_3$ -adrenergic receptor gene. Diabetes 45: 1115-1120 https://doi.org/10.2337/diabetes.45.8.1115
  46. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg AD, Stern MP, Raben N, Sorkin JD, Roth J, and Shuldiner AR (1995) Time of onset of noninsulin-dependent diabetes mellitus and genetic variation in the beta(3)-adrenergic-receptor gene. N Engl J Med 333: 343-347 https://doi.org/10.1056/NEJM199508103330603
  47. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC (1995) Association of a polymorphism in the beta(3)-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333: 348-351 https://doi.org/10.1056/NEJM199508103330604
  48. Yudkin JS, Alberti KGM, McCarty DG, and Swai ABM (1990) Impaired glucose tolerance: is it a risk factor for diabetes or a diagnostic ragbag? Br Med J 301: 397-402
  49. J Clin Invest v.89 Defective insulin response of phosphorylase physphatase in insulin-resistant humans Kida Y.;Raz I;Maeda R;Nyomba BL;Stone K;Bogardus C;Sommercorn J;Mott DM